Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development.

Schueler J, Klingner K, Bug D, Zoeller C, Maier A, Dong M, Willecke K, Peille AL, Steiner E, Landesfeind M, Copland JA, Siegers GM, Haferkamp A, Boehm K, Tsaur I, Schneider M.

Oncotarget. 2018 Jul 24;9(57):30946-30961. doi: 10.18632/oncotarget.25697. eCollection 2018 Jul 24.

2.

ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival.

Gilbert SM, Oliphant CJ, Hassan S, Peille AL, Bronsert P, Falzoni S, Di Virgilio F, McNulty S, Lara R.

Oncogene. 2019 Jan;38(2):194-208. doi: 10.1038/s41388-018-0426-6. Epub 2018 Aug 7.

3.

Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts.

Maier A, Peille AL, Vuaroqueaux V, Lahn M.

Cell Oncol (Dordr). 2015 Apr;38(2):131-44. doi: 10.1007/s13402-014-0210-8. Epub 2015 Jan 9.

4.

Prognostic value of PLAGL1-specific CpG site methylation in soft-tissue sarcomas.

Peille AL, Brouste V, Kauffmann A, Lagarde P, Le Morvan V, Coindre JM, Chibon F, Bresson-Bepoldin L.

PLoS One. 2013 Nov 15;8(11):e80741. doi: 10.1371/journal.pone.0080741. eCollection 2013.

5.

Correlating global gene regulation to angiogenesis in the developing chick extra-embryonic vascular system.

Javerzat S, Franco M, Herbert J, Platonova N, Peille AL, Pantesco V, De Vos J, Assou S, Bicknell R, Bikfalvi A, Hagedorn M.

PLoS One. 2009 Nov 17;4(11):e7856. doi: 10.1371/journal.pone.0007856. Erratum in: PLoS One. 2010;5(3). doi: 10.1371/annotation/110bdc8c-b16e-4043-816c-a3f8105ca061.

Supplemental Content

Loading ...
Support Center